Literature DB >> 8253712

Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells.

J L Duff1, M B Marrero, W G Paxton, C H Charles, L F Lau, K E Bernstein, B C Berk.   

Abstract

Angiotensin II is a potent growth factor for vascular smooth muscle cells and shares many signal transduction mechanisms with mitogens, including stimulation of mitogen-activated protein (MAP) kinases and protein tyrosine phosphorylation. Regulation of tyrosine phosphorylation involves both protein-tyrosine kinases and protein-tyrosine phosphatases (PTPases). To investigate the role of PTPases in angiotensin II-mediated events, we studied the expression of a transcriptionally regulated PTPase, 3CH134, which has selective activity toward MAP kinase. Angiotensin II rapidly induced 3CH134 mRNA (30 min maximum) in a concentration-dependent manner (100 nM maximum). Platelet-derived growth factor, alpha-thrombin, hydrogen peroxide, phorbol 12-myristate 13-acetate, and ionomycin also induced 3CH134 but to levels lower than angiotensin II. Induction of 3CH134 by angiotensin II was partially inhibited after down-regulating protein kinase C but was fully inhibited after chelating intracellular Ca2+. Treatment with both phorbol 12-myristate 13-acetate and ionomycin induced 3CH134 mRNA to levels seen with angiotensin II, indicating that Ca2+ mobilization and protein kinase C activation can act synergistically to induce 3CH134. Angiotensin II stimulated 3CH134 protein synthesis after 1 h as measured by immunoprecipitation of 3CH134 from [35S]methionine-labeled cells using affinity-purified antibodies. These results establish 3CH134 as a dynamically regulated, immediate early gene in vascular smooth muscle cells and suggest a role for PTPases in regulating angiotensin II-stimulated events mediated by MAP kinases and tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253712

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

2.  Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.

Authors:  Cheryl Isleib Blaukovitch; Raymond Pugh; Albert C Gilotti; Daniela Kanyi; Linda J Lowe-Krentz
Journal:  J Cell Biochem       Date:  2010-05-15       Impact factor: 4.429

3.  Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle.

Authors:  Danielle M Trappanese; Sarah Sivilich; Hillevi K Ets; Farah Kako; Michael V Autieri; Robert S Moreland
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

Review 4.  The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth.

Authors:  B Schieffer; K E Bernstein; M B Marrero
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

Review 5.  The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors.

Authors:  K Malarkey; C M Belham; A Paul; A Graham; A McLees; P H Scott; R Plevin
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

6.  Role of receptor desensitization, phosphatase induction and intracellular cyclic AMP in the termination of mitogen-activated protein kinase activity in UTP-stimulated EAhy 926 endothelial cells.

Authors:  A Graham; A McLees; K Malarkey; G W Gould; R Plevin
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

7.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

Authors:  M Nakajima; H G Hutchinson; M Fujinaga; W Hayashida; R Morishita; L Zhang; M Horiuchi; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  UAP56 is an important mediator of angiotensin II/platelet derived growth factor induced vascular smooth muscle cell DNA synthesis and proliferation.

Authors:  Abha Sahni; Nadan Wang; Jeffrey Alexis
Journal:  Biochem Biophys Res Commun       Date:  2012-12-12       Impact factor: 3.575

9.  Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.

Authors:  M Akishita; M Ito; J Y Lehtonen; L Daviet; V J Dzau; M Horiuchi
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation.

Authors:  K Lai; H Wang; W S Lee; M K Jain; M E Lee; E Haber
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.